GBS Venture Partners
Overview
GBS Venture Partners is a leading Australian venture capital firm founded in 1996, specializing in life sciences. The firm, headquartered in Melbourne, focuses on investments in human therapeutics, biotechnology, diagnostics, and medical devices. GBS invests in companies from early-stage development to later stages, taking an active board role and providing strategic support. Their geographic focus is primarily Australia, but they also invest in the U.S. and Oceania.
Portfolio Companies
3
Website
gbsventures.com.auInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Hatchtech Pty Ltd | Sep 2015 | M&A | Co-investor |
| Moximed | Aug 2024 | Series D | Co-investor |
| InflammX Therapeutics | Jul 2012 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is GBS Venture Partners based?
GBS Venture Partners is headquartered in Melbourne, Victoria, Australia.
When was GBS Venture Partners founded?
Founding year information for GBS Venture Partners is not publicly available.
How many portfolio companies does GBS Venture Partners have?
GBS Venture Partners has 3 portfolio companies in Caplight's dataset.
What are some companies in GBS Venture Partners's portfolio?
Portfolio companies visible on Caplight include Hatchtech Pty Ltd, Moximed, InflammX Therapeutics.
What was GBS Venture Partners's most recent investment shown here?
GBS Venture Partners's most recent investment in this portfolio sample was in Moximed in 2024.
What sectors does GBS Venture Partners focus on?
GBS Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does GBS Venture Partners focus on?
GBS Venture Partners typically invests at the Mid stage.